2/15/2018: We are pleased to announce in our press release, the details of our exclusive US distribution rights to the FDA approved exciplex® from Europe, a narrowband UVB phototherapy device for the treatment of psoriasis, atopic dermatitis(eczema), vitiligo and leukoplakia, and its availability for demonstration and sale at the 76th Annual Meeting of the American Academy of Dermatology, from Feb 16-18, in our booth 5429 at the show in San Diego.